Click for best price
Measles Mumps Rubella MMR Vaccines Market Size, Share 2024
Report Overview
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
This report provides a deep insight into the global Measles, Mumps and Rubella (MMR) Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Measles, Mumps and Rubella (MMR) Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Measles, Mumps and Rubella (MMR) Vaccines market in any manner.
Global Measles, Mumps and Rubella (MMR) Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
Market Segmentation (by Type)
Monovalent Vaccine
Polyvalent Vaccine
Market Segmentation (by Application)
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Measles, Mumps and Rubella (MMR) Vaccines Market
? Overview of the regional outlook of the Measles, Mumps and Rubella (MMR) Vaccines Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Measles, Mumps and Rubella (MMR) Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Global Measles, Mumps and Rubella (MMR) Vaccines Market Research Report 2024(Status and Outlook) |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
127 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Measles, Mumps and Rubella (MMR) Vaccines
1.2 Key Market Segments
1.2.1 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
1.2.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Measles, Mumps and Rubella (MMR) Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Landscape
3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Sales Sites, Area Served, Product Type
3.6 Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation and Trends
3.6.1 Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Measles, Mumps and Rubella (MMR) Vaccines Industry Chain Analysis
4.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Measles, Mumps and Rubella (MMR) Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Measles, Mumps and Rubella (MMR) Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2019-2024)
7 Measles, Mumps and Rubella (MMR) Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Sales by Application (2019-2024)
7.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate by Application (2019-2024)
8 Measles, Mumps and Rubella (MMR) Vaccines Market Segmentation by Region
8.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
8.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
8.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Medlmmune
9.1.1 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.1.2 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.1.4 Medlmmune Business Overview
9.1.5 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines SWOT Analysis
9.1.6 Medlmmune Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.2.2 Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.2.3 Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Merck
9.3.1 Merck Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.3.2 Merck Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Sanofi
9.4.1 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.4.2 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Serum
9.5.1 Serum Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.5.2 Serum Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.5.4 Serum Business Overview
9.5.5 Serum Recent Developments
9.6 Bavarian Nordic
9.6.1 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.6.2 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.6.4 Bavarian Nordic Business Overview
9.6.5 Bavarian Nordic Recent Developments
9.7 Astellas Pharma
9.7.1 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.7.2 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.7.4 Astellas Pharma Business Overview
9.7.5 Astellas Pharma Recent Developments
9.8 Emergent BioSolutions
9.8.1 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.8.2 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.8.4 Emergent BioSolutions Business Overview
9.8.5 Emergent BioSolutions Recent Developments
9.9 GlaxoSmithKline
9.9.1 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.9.2 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.9.4 GlaxoSmithKline Business Overview
9.9.5 GlaxoSmithKline Recent Developments
9.10 Pfizer
9.10.1 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.10.2 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 CSL
9.11.1 CSL Measles, Mumps and Rubella (MMR) Vaccines Basic Information
9.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Product Overview
9.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Product Market Performance
9.11.4 CSL Business Overview
9.11.5 CSL Recent Developments
10 Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Region
10.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast
10.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Region
10.2.4 South America Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Measles, Mumps and Rubella (MMR) Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Type (2025-2030)
11.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Measles, Mumps and Rubella (MMR) Vaccines by Type (2025-2030)
11.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Measles, Mumps and Rubella (MMR) Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2022)
Table 10. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Sales Sites and Area Served
Table 12. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Measles, Mumps and Rubella (MMR) Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
Table 22. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (Kilotons)
Table 23. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type (M USD)
Table 24. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) by Application
Table 30. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application (2019-2024)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 44. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 45. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Medlmmune Business Overview
Table 47. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines SWOT Analysis
Table 48. Medlmmune Recent Developments
Table 49. Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 50. Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 51. Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Measles, Mumps and Rubella (MMR) Vaccines SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Merck Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 56. Merck Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 57. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Measles, Mumps and Rubella (MMR) Vaccines SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 62. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 63. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Serum Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 67. Serum Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 68. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Business Overview
Table 70. Serum Recent Developments
Table 71. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 72. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 73. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bavarian Nordic Business Overview
Table 75. Bavarian Nordic Recent Developments
Table 76. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 77. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 78. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Astellas Pharma Business Overview
Table 80. Astellas Pharma Recent Developments
Table 81. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 82. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 83. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Emergent BioSolutions Business Overview
Table 85. Emergent BioSolutions Recent Developments
Table 86. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 87. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 88. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Recent Developments
Table 91. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 92. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 93. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Pfizer Business Overview
Table 95. Pfizer Recent Developments
Table 96. CSL Measles, Mumps and Rubella (MMR) Vaccines Basic Information
Table 97. CSL Measles, Mumps and Rubella (MMR) Vaccines Product Overview
Table 98. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CSL Business Overview
Table 100. CSL Recent Developments
Table 101. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Measles, Mumps and Rubella (MMR) Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country (M USD)
Figure 11. Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Type
Figure 18. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2023
Figure 20. Market Size Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application
Figure 24. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2023
Figure 26. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application (2019-2024)
Figure 27. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application in 2023
Figure 28. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2023
Figure 44. China Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Measles, Mumps and Rubella (MMR) Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share Forecast by Application (2025-2030)
